by Symmetron | Jan 21, 2019
Rheumatoid arthritis  Tocilizumab in methotrexate-naïve rheumatoid arthritis: a cost-utility model for Slovakia Value in Health. 2015;18(7):A648 Authors Chang S, Sawyer L, Dejonckheere F, Grichova L, Diamantopoulos A For more information about health economic...
Recent Comments